Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal ropivacaine concentration and volume for single-shot femoral nerve block in knee arthroscopic meniscoplasty
ChiCTR2000034895Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Aug 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ropivacaine in meniscal tear (4 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Degree of sensory block in the anterior thigh and patellar femoral nerve distribution, Quadriceps muscle strength and 1 more. Planned start Aug 2020; status: not yet recruiting.
02
Drugs
ropivacaine
03
Conditions
meniscal tear
Beyond the preview
Go deeper on ChiCTR2000034895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034895.